Respiratory therapy

NRI USA Medical Suppliers, TrueVision Technologies and Peach Medical Sourcing, Team-Up to Supply India Oxygen Concentrators

Retrieved on: 
Friday, May 28, 2021
Industrial gases, Oxygen, Medicine, Health sciences, Clinical medicine, Respiratory therapy, Dosage forms, Medical equipment, Oxygen concentrator, Oxygen therapy, Oxygen tank

Since late March 2021, India has been facing a new wave of a Covid-19 variant that has crippled the existing healthcare infrastructure.

Key Points: 
  • Since late March 2021, India has been facing a new wave of a Covid-19 variant that has crippled the existing healthcare infrastructure.
  • "Our team quickly sprung into action and worked with our distributors to purchase oxygen concentrators for NGOs, private donors, and individuals.
  • "To complement our US team's efforts, we have contracted with 3 Chinese manufacturers through our local subsidiary to provide India specification 220V oxygen concentrators," says Nitin Khosla, CEO of Peach Medical Sourcing.
  • We have 2 planes leaving weekly filled with all relief supplies including oxygen concentrators and accessories, oxygen tanks, masks, gowns and much more."

Shop LC Donates Oxygen Plants to Indian Hospitals as Part of Relief Efforts

Retrieved on: 
Thursday, May 27, 2021
Oxygen, Industrial gases, Medicine, Health sciences, Clinical medicine, Respiratory therapy, Medical equipment, Oxygen concentrator, Shop LC, Santokba Durlabhji Memorial hospital, Chemical oxygen generator, Lifestyle

The oxygen generator plant has the capacity to supply 150 beds of oxygen to Santokba Durlabhji Memorial Hospital, Jaipur, India.

Key Points: 
  • The oxygen generator plant has the capacity to supply 150 beds of oxygen to Santokba Durlabhji Memorial Hospital, Jaipur, India.
  • In addition to the oxygen plants, the Shop LC team has also collaborated to provide over 50 oxygen concentrators and BiPap machines.
  • Since March 2020, the Shop LC team has provided support in many ways to both the community and employees by developing a line of essential products.
  • Shop LC is a value-conscious, interactive retailer focused on the fine jewelry, beauty, fashion, home decor and lifestyle product categories.

Premium Manufacturing Solutions Company Sending Oxygen to India

Retrieved on: 
Thursday, May 27, 2021
Oxygen, Industrial gases, Chemistry, Medicine, Physical sciences, Respiratory therapy, Dosage forms, Medical equipment, Oxygen concentrator, Oxygen therapy, Oxygen mask, Oxygen tank

SHANGHAI, May 27, 2021 /PRNewswire/ -- International sourcing company Source Access has extended their corporate responsibility to contribute to the growing oxygen concerns in India.

Key Points: 
  • SHANGHAI, May 27, 2021 /PRNewswire/ -- International sourcing company Source Access has extended their corporate responsibility to contribute to the growing oxygen concerns in India.
  • Source Access is working with hospitals in India to help get them Oxygen Concentrators.
  • Global systems regulate who can receive oxygen, and with it being a lifesaving treatment for the virus, many oxygen systems in hospitals across India require refills that they are not getting access to.
  • "We've dedicated our team to secure PPE products such as oxygen tanks to go out to India as priority shipments."

Spirometer Markets, 2026: Hand-Held, Table Top & Desktop - Market is Projected to Grow at the Rate of 11.7% CAGR - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 26, 2021
Medical devices, Health, Spirometer, Compound annual growth rate, Respiratory therapy

The Spirometer Market is projected to grow at the rate of 11.7% CAGR by 2026.

Key Points: 
  • The Spirometer Market is projected to grow at the rate of 11.7% CAGR by 2026.
  • However, limited skilled professionals and inadequate awareness about respiratory disorders' symptoms are the factors restricting the spirometer market growth.
  • As per the end-user of the spirometer market, the hospitals are the significant end-users of this market.
  • Moreover, the rising consciousness about the advanced diagnostic methods among consumers further favors the spirometer market growth.

RYAH Medtech Inc. Ships Devices for Use in Pilot Study with CLINN Medical Center

Retrieved on: 
Tuesday, May 25, 2021
Dosage forms, Medtech, Asthma, Respiratory therapy, Zimmer Biomet Robotics, Inhaler, Health sciences, Health care, Health

NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- RYAH Group, Inc.s (CSE:RYAH) (RYAH or the Company) wholly owned subsidiary, RYAH Medtech Inc. (RYAH Medtech), announces it has completed initial shipment of its proprietary Smart Dose-Measuring inhalers for use in a pilot study conducted by CLINN medical center in Milan, Italy.

Key Points: 
  • NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- RYAH Group, Inc.s (CSE:RYAH) (RYAH or the Company) wholly owned subsidiary, RYAH Medtech Inc. (RYAH Medtech), announces it has completed initial shipment of its proprietary Smart Dose-Measuring inhalers for use in a pilot study conducted by CLINN medical center in Milan, Italy.
  • We are delighted to bring RYAH Medtech's Smart-Inhaler to the CLINN network and support CLINN in integrating their data collection software.
  • RYAH Medtech Inc. (RYAH) is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry.
  • With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.

Vapotherm to Participate in the William Blair 41st Annual Growth Stock Conference

Retrieved on: 
Tuesday, May 25, 2021
Health, Medical Supplies, Other Health, Medical devices, Medical specialties, Medicine, Clinical medicine, Respiratory therapy, Medical emergencies, Respiratory diseases, Ventilator, Hypercapnia, Vapotherm, Respiratory therapist

Vapotherm, Inc. (NYSE: VAPO), (Vapotherm or the Company), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy products, which are used to treat patients of all ages suffering from respiratory distress, today announced that its management team will be participating in the William Blair 41st Annual Growth Stock Conference on Tuesday, June 1, 2021 via webcast.

Key Points: 
  • Vapotherm, Inc. (NYSE: VAPO), (Vapotherm or the Company), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy products, which are used to treat patients of all ages suffering from respiratory distress, today announced that its management team will be participating in the William Blair 41st Annual Growth Stock Conference on Tuesday, June 1, 2021 via webcast.
  • Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA.
  • Over 2.8 million patients have been treated with the use of Vapotherm high velocity therapy systems.
  • Vapotherm high velocity therapy is mask-free noninvasive ventilatory support and is a front-line tool for relieving respiratory distressincluding hypercapnia, hypoxemia, and dyspnea.

Verona Pharma to Present at Jefferies Virtual Healthcare Conference

Retrieved on: 
Tuesday, May 25, 2021
Respiratory therapy, Health sciences, Health, Chronic lower respiratory diseases, Dosage forms, Chronic obstructive pulmonary disease, Nebulizer, Forward-looking statement

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.

Key Points: 
  • Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.
  • The Company is evaluating nebulized ensifentrine in its Phase 3 clinical program ENHANCE (Ensifentrine as a Novel inHAled Nebulized COPD thErapy) for COPD maintenance treatment.
  • All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements.
  • These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

2021 Insights on the Chronic Obstructive Pulmonary Disease Global Market - Identify Patients Segments Through Age Groups, Gender and Disease Sub-Types - ResearchAndMarkets.com

Retrieved on: 
Monday, May 24, 2021
Infectious diseases, Pharmaceutical, Health, Cardiology, Medicine, Chronic condition, Medical terminology, Respiratory therapy, Hypertension, Health care, Lung disorders, Health, Pulmonary hypertension, Chronic lung disease

The "Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
  • The research report, Global Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2021, provides Chronic Obstructive Pulmonary Disease epidemiology, demographics, and patient flow.
  • The research provides population data to characterize Chronic Obstructive Pulmonary Disease patients, history of the disease at the population level (Chronic Obstructive Pulmonary Disease prevalence, Chronic Obstructive Pulmonary Disease incidence) and at the clinical level (from diagnosis to treated patients).
  • Chronic Obstructive Pulmonary Disease patient flow: Chronic Obstructive Pulmonary Disease prevalence, diagnosed, and drug-treated patients
    Demographics: Chronic Obstructive Pulmonary Disease patients by age group, gender
    The data from this research will help executives:
    Establish basis for Chronic Obstructive Pulmonary Disease market sizing, assessing market potential, and developing drug forecast models
    Identify Chronic Obstructive Pulmonary Disease patients segments through age groups, gender, and disease sub-types
    Evaluate Chronic Obstructive Pulmonary Disease market opportunities, identify target patient population
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005522/en/

In Utero Exposure to Tiny Pollution Particles in the Air Is Linked to Asthma in Preschoolers, Study Shows

Retrieved on: 
Friday, May 21, 2021
Air pollution, Climate forcing, Aerosols, Respiratory therapy, Particulates, Visibility, Asthma, Health, Clinical medicine, Medical specialties

These have been associated with asthma risk in children in prior research.

Key Points: 
  • These have been associated with asthma risk in children in prior research.
  • Because of this, the researchers said their toxic effects may actually be greater.\n"One reason ultra-fine particulates are not routinely monitored is that there have been a number of unique challenges to measuring them accurately.
  • Most of the diagnoses of asthma occurred just after three years of age.\nPollution\'s effect in utero can alter lung development and respiratory health.
  • As we advance methods for measuring these tiny particles, we hope for replication of these findings, both within different geographic areas across the United States as well as globally.

Advanced Oxygen Therapy Inc. Named Among the 10 Most Innovative MedTech Solution Providers to Watch in 2021

Retrieved on: 
Thursday, May 20, 2021
Health sciences, Medicine, Clinical medicine, Necrosis, Oxygen, Chronic wound, Diving medicine, Industrial gases, Respiratory therapy, Wound, Therapy, Oxygen therapy

b'OCEANSIDE, Calif., May 20, 2021 /PRNewswire/ --Advanced Oxygen Therapy Inc. (AOTI) announced today that it had been named among the 10 Most Innovative MedTech Solution Providers to Watch in 2021 by the journal The Healthcare Insights and is highlighted as the cover story of its May 2021 print edition.\nThe article ( https://thehealthcareinsights.com/advanced-oxygen-therapy-inc-dedicated-... ) details how AOTI is dedicated to resolving acute and chronic wounds through its patented cyclical-pressure Topical Wound Oxygen (TWO2) therapy.

Key Points: 
  • b'OCEANSIDE, Calif., May 20, 2021 /PRNewswire/ --Advanced Oxygen Therapy Inc. (AOTI) announced today that it had been named among the 10 Most Innovative MedTech Solution Providers to Watch in 2021 by the journal The Healthcare Insights and is highlighted as the cover story of its May 2021 print edition.\nThe article ( https://thehealthcareinsights.com/advanced-oxygen-therapy-inc-dedicated-... ) details how AOTI is dedicated to resolving acute and chronic wounds through its patented cyclical-pressure Topical Wound Oxygen (TWO2) therapy.
  • Thereby providing clinically proven complete healing outcomes and wound protective care to high-risk patients safely at home.
  • Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses.
  • Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is unsurpassed in closing all chronic wound types.\n'